Intermittent bolus feeding promotes greater lean growth than continuous feeding in a neonatal piglet model.
Samer W El-Kadi, Claire Boutry, Agus Suryawan...
https://pubmed.ncbi.nlm.nih.gov/30239549Actively Recruiting
Led by University of British Columbia · Updated on 2026-02-12
96
Participants Needed
1
Research Sites
32 weeks
Total Duration
Researchers are evaluating how different ways of giving dietary protein affect nutrition markers like weight and muscle mass in critically ill children aged 1 to 11 years. The study aims to see if giving protein in bolus doses reduces the loss of mid-upper arm circumference compared to continuous delivery, and whether this method better meets daily protein needs. This pilot study is conducted in a pediatric intensive care unit setting with careful monitoring and data collection. Participants will be randomly assigned to one of two groups: one receiving protein continuously mixed into enteral formula around the clock, and the other receiving supplemental protein as bolus doses every 4 hours alongside continuous formula feeding. Both groups will get the same amount of protein, aiming for 1 gram per kilogram per day of supplemental protein in addition to standard enteral nutrition. The intervention starts within the first few days of admission and lasts as long as the patient meets study criteria. Children in the study will have their nutrition intake tracked daily and undergo body composition assessments including weight, mid-upper arm circumference, and ultrasound measurements of thigh muscle at admission and on days 3, 5, 7, and 14 post-intervention start. Researchers will monitor changes over time and any significant clinical events to understand protein delivery effects and ensure data accuracy. The study includes follow-ups for up to two weeks with ongoing data analysis to evaluate outcomes.
CONDITIONS
Continuous vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids In Distress)
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - Up to 14 days after admission
Participants are screened for eligibility to participate in the trial.
Screening and enrollment visit within 48 hours of admission if appropriate
Duration - Typically starting within 72 to 96 hours after admission and continuing until discharge or change in nutrition regimen
Participants receive either continuous or bolus dietary protein supplementation alongside standard enteral nutrition to evaluate protein delivery methods.
Daily assessments during intervention for up to 14 days
Duration - 14 days from admission
Participants undergo nutrition status assessments including measurements of mid-upper arm circumference and quadricep ultrasound at admission, 7 days, and 14 days.
3 visits (at admission, Day 7, and Day 14)
Total: 1 location
1
BC Childrens Hospital
Vancouver, British Columbia, Canada, V6H 3N1
Actively Recruiting
K
Kaitlin A Berris, BSc
R
Rajavel Elango, PhD
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Samer W El-Kadi, Claire Boutry, Agus Suryawan...
https://pubmed.ncbi.nlm.nih.gov/30239549Teresa A Davis, Marta L Fiorotto, Agus Suryawan
https://pubmed.ncbi.nlm.nih.gov/25474017Marko Rudar, Jane K Naberhuis, Agus Suryawan...
https://pubmed.ncbi.nlm.nih.gov/34719946Chengsi Ong, Jan Hau Lee, Stephanie Senna...
https://pubmed.ncbi.nlm.nih.gov/30958426Chengsi Ong, Jan Hau Lee, Judith J M Wong...
https://pubmed.ncbi.nlm.nih.gov/33861558Delia Valverde Montoro, Vanesa Rosa Camacho, Lourdes Artacho González...
https://pubmed.ncbi.nlm.nih.gov/37782351Jessie M Hulst, Koen Huysentruyt, Konstantinos Gerasimidis...
https://pubmed.ncbi.nlm.nih.gov/35258497Patricia Becker, Liesje Nieman Carney, Mark R Corkins...
https://pubmed.ncbi.nlm.nih.gov/25422273